Bio Green Med Solution, Inc. (NASDAQ: BGMS) Stock Competitors & Peer Comparison
See BGMS's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BGMS and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BGMS | $0.91 | -0.64% | 5M | -0.26 | -$3.56 | N/A |
| RPRX | $59.45 | +1.45% | 26.4B | 11.32 | $5.25 | +1.56% |
| CORT | $117.17 | +2.36% | 12.7B | 334.77 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $77.70 | +4.38% | 6.9B | 555.00 | $0.14 | N/A |
| KNSA | $79.18 | +3.17% | 6B | 87.98 | $0.90 | N/A |
| TRLV | $9.47 | -1.87% | 1.6B | -22.60 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $19.30 | -0.97% | 1.2B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
BGMS vs RPRX Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, RPRX has a market cap of 26.4B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while RPRX trades at $59.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas RPRX's P/E ratio is 11.32. In terms of profitability, BGMS's ROE is -0.32%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, BGMS is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
BGMS vs CORT Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CORT has a market cap of 12.7B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while CORT trades at $117.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CORT's P/E ratio is 334.77. In terms of profitability, BGMS's ROE is -0.32%, compared to CORT's ROE of +0.08%. Regarding short-term risk, BGMS is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
BGMS vs WBA Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas WBA's P/E ratio is -1.64. In terms of profitability, BGMS's ROE is -0.32%, compared to WBA's ROE of -0.42%. Regarding short-term risk, BGMS is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
BGMS vs LQDA Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, LQDA has a market cap of 6.9B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while LQDA trades at $77.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas LQDA's P/E ratio is 555.00. In terms of profitability, BGMS's ROE is -0.32%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, BGMS is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
BGMS vs KNSA Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while KNSA trades at $79.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas KNSA's P/E ratio is 87.98. In terms of profitability, BGMS's ROE is -0.32%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, BGMS is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
BGMS vs TRLV Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, TRLV has a market cap of 1.6B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while TRLV trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas TRLV's P/E ratio is -22.60. In terms of profitability, BGMS's ROE is -0.32%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, BGMS is less volatile compared to TRLV. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
BGMS vs HROWL Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas HROWL's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, BGMS is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
BGMS vs HROWM Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas HROWM's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, BGMS is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
BGMS vs LTGO Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, LTGO has a market cap of 1.2B. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while LTGO trades at $19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas LTGO's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to LTGO's ROE of N/A. Regarding short-term risk, BGMS is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check LTGO's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
BGMS vs CUVL Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CUVL has a market cap of 346.7M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while CUVL trades at $6.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CUVL's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to CUVL's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
BGMS vs LFMD Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, LFMD has a market cap of 160.6M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while LFMD trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas LFMD's P/E ratio is -6.64. In terms of profitability, BGMS's ROE is -0.32%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, BGMS is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check LFMD's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
BGMS vs LFMDP Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, LFMDP has a market cap of 158.7M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while LFMDP trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas LFMDP's P/E ratio is -717.10. In terms of profitability, BGMS's ROE is -0.32%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, BGMS is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check LFMDP's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
BGMS vs CIRC Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CIRC has a market cap of 57.8M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while CIRC trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CIRC's P/E ratio is -1.46. In terms of profitability, BGMS's ROE is -0.32%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, BGMS is less volatile compared to CIRC. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CIRC's competition here
Stablecoin Development Corp. (AMEX: SDEV)
BGMS vs SDEV Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SDEV has a market cap of 51.5M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while SDEV trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SDEV's P/E ratio is -0.18. In terms of profitability, BGMS's ROE is -0.32%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, BGMS is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check SDEV's competition here
Rite Aid Corporation (NYSE: RAD)
BGMS vs RAD Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas RAD's P/E ratio is -0.05. In terms of profitability, BGMS's ROE is -0.32%, compared to RAD's ROE of +2.76%. Regarding short-term risk, BGMS is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
BGMS vs GLTO Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas GLTO's P/E ratio is -1.78. In terms of profitability, BGMS's ROE is -0.32%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, BGMS is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
BGMS vs SCYX Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SCYX has a market cap of 32.6M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while SCYX trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SCYX's P/E ratio is -1.51. In terms of profitability, BGMS's ROE is -0.32%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, BGMS is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check SCYX's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
BGMS vs NSRX Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, NSRX has a market cap of 31.2M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while NSRX trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas NSRX's P/E ratio is -5.03. In terms of profitability, BGMS's ROE is -0.32%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, BGMS is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check NSRX's competition here
Cerenome, Inc. (NASDAQ: CNSY)
BGMS vs CNSY Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CNSY has a market cap of 22M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while CNSY trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CNSY's P/E ratio is -0.44. In terms of profitability, BGMS's ROE is -0.32%, compared to CNSY's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
BGMS vs BFRI Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, BFRI has a market cap of 17.3M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while BFRI trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas BFRI's P/E ratio is -2.45. In terms of profitability, BGMS's ROE is -0.32%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, BGMS is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check BFRI's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
BGMS vs AIXC Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, AIXC has a market cap of 14.4M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while AIXC trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas AIXC's P/E ratio is -0.08. In terms of profitability, BGMS's ROE is -0.32%, compared to AIXC's ROE of -0.97%. Regarding short-term risk, BGMS is less volatile compared to AIXC. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check AIXC's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
BGMS vs CJJD Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CJJD's P/E ratio is -0.46. In terms of profitability, BGMS's ROE is -0.32%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, BGMS is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
BGMS vs SSY Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SSY's P/E ratio is -2.86. In terms of profitability, BGMS's ROE is -0.32%, compared to SSY's ROE of -0.09%. Regarding short-term risk, BGMS is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
BGMS vs POM Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, POM has a market cap of 5.9M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while POM trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas POM's P/E ratio is -0.17. In terms of profitability, BGMS's ROE is -0.32%, compared to POM's ROE of +0.16%. Regarding short-term risk, BGMS is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
BGMS vs PAVS Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, PAVS has a market cap of 5.4M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while PAVS trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas PAVS's P/E ratio is -0.07. In terms of profitability, BGMS's ROE is -0.32%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, BGMS is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
BGMS vs HKPD Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, HKPD has a market cap of 4.5M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while HKPD trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas HKPD's P/E ratio is -6.87. In terms of profitability, BGMS's ROE is -0.32%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, BGMS is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check HKPD's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
BGMS vs MDVL Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas MDVL's P/E ratio is -0.05. In terms of profitability, BGMS's ROE is -0.32%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, BGMS is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
BGMS vs ATNFW Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas ATNFW's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, BGMS is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
BGMS vs BGMSP Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, BGMS's ROE is -0.32%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, BGMS is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
BGMS vs AZNH Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas AZNH's P/E ratio is 38.35. In terms of profitability, BGMS's ROE is -0.32%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, BGMS is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
BGMS vs LFLYW Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, BGMS's ROE is -0.32%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, BGMS is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
BGMS vs SBFMW Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SBFMW has a market cap of 155.2K. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while SBFMW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SBFMW's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to SBFMW's ROE of -0.24%. Regarding short-term risk, BGMS is more volatile compared to SBFMW. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check SBFMW's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
BGMS vs OREX Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, OREX has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas OREX's P/E ratio is -0.14. In terms of profitability, BGMS's ROE is -0.32%, compared to OREX's ROE of -0.54%. Regarding short-term risk, BGMS is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check OREX's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
BGMS vs CPD Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CPD has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas CPD's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to CPD's ROE of N/A. Regarding short-term risk, BGMS is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CPD's competition here
Shire plc (NASDAQ: SHPG)
BGMS vs SHPG Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas SHPG's P/E ratio is 11.35. In terms of profitability, BGMS's ROE is -0.32%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, BGMS is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check SHPG's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
BGMS vs IPXL Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas IPXL's P/E ratio is -10.11. In terms of profitability, BGMS's ROE is -0.32%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, BGMS is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check IPXL's competition here
POZEN Inc. (NASDAQ: POZN)
BGMS vs POZN Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, POZN has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas POZN's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to POZN's ROE of +0.61%. Regarding short-term risk, BGMS is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check POZN's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
BGMS vs ESRX Comparison August 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.91 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.26, whereas ESRX's P/E ratio is 10.69. In terms of profitability, BGMS's ROE is -0.32%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, BGMS is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check ESRX's competition here